Jean-marc Payrat - Publications

Longitudinal analysis of annual national hemovigilance data to assess pathogen reduced platelet transfusion trends during conversion to routine universal clinical use and 7-day storage.

Journal: Transfusion

Published: October 03, 2022

Preparation and Storage of Cryoprecipitate Derived from Amotosalen and UVA-Treated Apheresis Plasma and Assessment of In Vitro Quality Parameters.

Journal: Pathogens (Basel, Switzerland)

Published: May 31, 2022

Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction.

Journal: Transfusion

Published: December 17, 2021

Pathogen inactivation treatment of triple-dose apheresis platelets with amotosalen and ultraviolet a light.

Journal: Transfusion medicine (Oxford, England)

Published: September 16, 2021

Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light.

Journal: Transfusion

Published: January 09, 2020

Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpura.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: May 17, 2019

Investigative in vitro study about red blood cell concentrate processing and storage.

Journal: American journal of respiratory and critical care medicine

Published: January 17, 2013

The effects of red blood cell preparation method on in vitro markers of red blood cell aging and inflammatory response.

Journal: Transfusion

Published: August 10, 2012